Log in or Sign up for Free to view tailored content for your specialty!
Interventional Endoscopy News
Duodenal mucosal resurfacing granted FDA breakthrough label for weight loss maintenance
The FDA granted breakthrough device designation for an endoscopic procedure that resurfaces the duodenum lining to allow for weight maintenance after discontinuation of a GLP-1 receptor agonist, according to an industry press release.
Gastric bypass for obesity lowers major atherogenic blood lipids vs. very low-energy diet
Patients with severe obesity undergoing Roux-en-Y gastric bypass for weight loss demonstrated greater reductions in blood lipids at 6 weeks vs. those on a very low-energy diet, according to study results in JAMA Surgery.
Log in or Sign up for Free to view tailored content for your specialty!
#StopUHC campaign calls on insurer to rethink looming ‘Gold card program’ for GI endoscopy
As part of its ongoing campaign against UnitedHealthcare and the insurer’s plans to implement the Gold Card program for gastrointestinal endoscopy procedures, AGA encourages all supporters to use the hashtag #StopUHC on social media.
Bariatric surgery significantly reduced major adverse liver outcomes in MASH cirrhosis
At 15 years of follow-up, metabolic surgery “was not only safe” but also significantly reduced major adverse liver outcomes and decompensation in patients with metabolic dysfunction-associated steatohepatitis and compensated cirrhosis.
GLP-1s not tied to higher risk for surgical complications for adults with diabetes
Adults with diabetes who used a GLP-1 receptor agonist and underwent surgery requiring general anesthesia had similar odds for postsurgical complications as those receiving other oral diabetes medications, according to study data.
Bariatric surgery associated with lower mortality, health care cost in patients with MASLD
WASHINGTON — Bariatric surgery was associated with improved clinical outcomes and more cost-effective health care resource utilization among patients with metabolic dysfunction-associated steatotic liver disease, according to data.
‘Durable’ weight loss: Endoscopic gastric remodeling surgery effective in managing obesity
WASHINGTON — The Primary Obesity Surgery Endoluminal 2.0 procedure is a “safe, effective and durable option” for weight loss and improvement in obesity-related conditions, according to a presenter.
Follow-up colonoscopy for diverticulitis ‘unlikely to provide benefit’ beyond CRC screening
Most patients undergoing colonoscopy after diverticulitis had low risk for colorectal cancer, except those with complicated diverticulitis, whose risk was nearly four times greater than the screening population, according to research.
Endoscopic ablation reduces primary hunger hormone by up to 53% in obesity
Endoscopic ablation of the gastric fundus reduced ghrelin, the primary hunger hormone, and resulted in significant weight loss among a small cohort of female patients with obesity, according to research.
Like ‘smoking a cigarette’: Endoscopists exposed to harmful pollutants during procedures
Endoscopists are exposed to dangerous levels of air pollutants when performing smoke-producing gastrointestinal endoscopic procedures — “comparable to smoking a cigarette” during a single procedure, according to researchers.
-
Headline News
Burnout, withdrawal remain ‘alarmingly high’ among physicians and residents
September 17, 20242 min read -
Headline News
Over one-third of adults not planning on receiving recommended vaccines this fall
September 18, 20242 min read -
Headline News
Popular home BP devices unable to provide accurate readings for millions due to sizing
September 19, 20242 min read
-
Headline News
Burnout, withdrawal remain ‘alarmingly high’ among physicians and residents
September 17, 20242 min read -
Headline News
Over one-third of adults not planning on receiving recommended vaccines this fall
September 18, 20242 min read -
Headline News
Popular home BP devices unable to provide accurate readings for millions due to sizing
September 19, 20242 min read